December 2012 Editor's Picks: Products from Honeywell Process Solutions and Carl Zeiss Microscopy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

December 2012 Editor's Picks: Products from Honeywell Process Solutions and Carl Zeiss Microscopy

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Honeywell Process Solutions
A smart pressure transmitter is redesigned for improved performance

The Smartline pressure transmitter from Honeywell Process Solutions enhances communication abilities, improves operational efficiency, and reduces lifecycle costs. As part of the Smart Connection Suite, the display is capable of showing process data in graphical formats and communicating messages from the control room, which makes it easier for field operators to determine required maintenance tasks. The transmitter can also be integrated with Honeywell’s Experion Process Knowledge System, through which field operators can identify if the control loop is in a safe state to perform maintenance. A modular design simplifies repairs and reduces cost by allowing replacement of individual components instead of the entire unit. Other safety and efficiency features include enhanced security alerts and wiring polarity insensitivity, through which the transmitter will function correctly even if wiring polarity is reversed.

Carl Zeiss Microscopy
Microscopy is used to monitor cleanliness and evaluate particles

The Axio Zoom.V16 from the Carl Zeiss Microscopy business group allows efficient investigation of a component’s cleanliness in various applications, including pharmaceutical manufacturing. Particles are classed as reflecting or nonreflecting in an automatic process using a motorized, intermediate tube for polarization contrast. The filter analysis with the AxioVision Particle Analyzer software module provides data on the concentration, size distribution, and type of particles. In addition, correlative microscopy, which combines light and electron microscopy, provides chemical information and material classification for individual particles.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here